Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
HS
Henry Schein Inc
HSIC
Mkt Cap
$9.62B
Volume
961.43K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
HS
HSIC
HS
Henry Schein Inc
HSIC
News
·
HSIC or MMSI: Which Is the Better Value Stock Right Now?
Mkt Cap
$9.69B
Volume
961.43K
Next Earnings
November 3rd
Chart
Financials
Earnings
News
About
Insider
Filings
HSIC or MMSI: Which Is the Better Value Stock Right Now?
In a comparison of two Medical-Dental Supplies stocks, Henry Schein (HSIC) and Merit Medical (MMSI), both holding a Zacks Rank #2 (Buy), HSIC emerges as the superior value opportunity. HSIC has a lower forward P/E ratio of 15.72 compared to MMSI's 20.29, a better PEG ratio of 1.49 versus 1.94, and a lower P/B ratio of 2.46 versus 3.1. HSIC received a Value grade of A while MMSI received a C grade.
Zacks Investment Research · Oct 6, 2026
Should Value Investors Buy Henry Schein (HSIC) Stock?
Henry Schein (HSIC) is highlighted as a compelling value investment opportunity, holding a Zacks Rank #2 (Buy) rating and an A grade for Value. The stock trades at a P/E ratio of 13.27, significantly below its industry average of 17.20, and demonstrates attractive valuations across multiple metrics including P/B, P/S, and P/CF ratios, suggesting it is currently undervalued in the market.
Zacks Investment Research · Oct 6, 2026
Global Shift to Clear Aligners to Build a USD 99.44 Billion Market by 2034
The global clear aligners market is valued at $11.23 billion in 2026 and is expected to grow to $99.44 billion by 2034, expanding at a 31.34% CAGR. North America leads the market while Asia Pacific shows the fastest growth. Adults dominate by age segment, polyurethane leads by material type, and online distribution channels are expected to grow fastest. Key drivers include rising demand for aesthetic orthodontic solutions, technological advancements in 3D imaging and AI, and expanding access through digital platforms.
GlobeNewswire Inc. · Feb 10, 2026
Growth of the Invisible Orthodontics Market From USD 7.7 Billion in 2024 to USD 96.27 Billion by 2034, Driven by a CAGR of 28.54%
The global invisible orthodontics market is projected to grow from USD 9.91 billion in 2025 to USD 96.27 billion by 2034, expanding at a CAGR of 28.54%. Clear aligners dominate the product segment, with North America leading regionally and Asia-Pacific showing significant growth potential. Adults currently represent the largest age segment, while the teens segment is expected to grow rapidly. Key drivers include rising dental misalignment cases, technological advancements in 3D printing, and increased consumer awareness of aesthetic dental solutions.
GlobeNewswire Inc. · Feb 5, 2026
United States Personal Protective Equipment (Gowns, Masks, Face Shields and Others) Market Outlook to 2033
A comprehensive market report on the U.S. Personal Protective Equipment market covering gowns, masks, face shields, gloves and other segments through 2033. The report provides revenue, volume, and pricing data across market segments with company share information for 2024, identifying key opportunities for market entry, expansion, and investment strategies.
GlobeNewswire Inc. · Feb 4, 2026
Sleeping Bruxism Treatment Market Size to Reach USD 1,132.09 Million by 2033, Driven by Rising Awareness of Sleep Disorders and Oral Health Complications – SNS Insider
The global sleeping bruxism treatment market is projected to grow from USD 652.14 million in 2025 to USD 1,132.09 million by 2033, expanding at a 7.18% CAGR. Growth is driven by rising awareness of sleep disorders, increasing stress levels, and demand for oral appliances and behavioral therapies. Occlusal splints and night guards dominate the market, while biofeedback therapy devices represent the fastest-growing segment. North America leads with 40% market share, while Asia Pacific is expected to grow fastest at 9.25% CAGR.
GlobeNewswire Inc. · Jan 28, 2026
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan
Zuckerman Investment Group increased its Henry Schein stake by 72,040 shares in Q3, bringing its position to 281,339 shares valued at $18.67 million. The purchase reflects confidence in Henry Schein's improving fundamentals, including 5% revenue growth to $3.3 billion, 13% non-GAAP EPS growth to $1.38, and a new $200 million efficiency plan. The company also repurchased $229 million in stock during the quarter.
The Motley Fool · Dec 29, 2025
New Two-Volume Book UNJUST GAGGLE OF GAVELS Exposes Corruption in Oklahoma Medical Laboratory Industry
Entrepreneur William Brooke Webb Jr. alleges that Henry Schein employee secretly opened a competing lab and sabotaged his business, leading to a two-volume book exposing corruption in the Oklahoma medical laboratory industry.
GlobeNewswire Inc. · Nov 13, 2025
Henry Schein Expands Strategic Partnership With KKR, Raises Annual Outlook
Henry Schein reported strong Q3 earnings, beating consensus estimates with $1.38 adjusted earnings per share and $3.34 billion in sales. The company expanded its strategic partnership with KKR and raised its fiscal 2025 guidance for earnings and sales.
Benzinga · Nov 4, 2025
Henry Schein (HSIC) Q2 EPS Drops 11%
Healthcare solutions distributor Henry Schein reported Q2 2025 financial results with mixed performance, experiencing revenue growth but declining profitability due to margin pressures in dental operations and increased restructuring costs.
The Motley Fool · Aug 5, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
HS
HSIC
Henry Schein Inc
Buy
Sell
Market
Limit
Soon
HSIC
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any HSIC yet.
Related Tickers
AM
AMN
—
WS
WST
—
NV
NVST
—
ID
IDXX
—
BI
BIO
—
MM
MMSI
—
Earnings